Trulicity vs. Glimepiride
See how Trulicity and Glimepiride compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Trulicity is a once-weekly injectable GLP-1 that also lowers cardiovascular risk, while glimepiride is a once-daily pill that only targets blood sugar.
Glimepiride costs far less than Trulicity but carries a higher risk of hypoglycemia and possible weight gain.
Trulicity is approved for children 10 and older, while glimepiride is approved for adults with type 2 diabetes only.
Trulicity vs. Glimepiride Drug Summary
Trulicity
Trulicity (dulaglutide) is a GLP-1 receptor agonist that helps the body release more insulin after meals and slows digestion. It treats type 2 diabetes in adults and children 10 and older, and also lowers cardiovascular risk in adults with heart disease. It is injected once a week using a prefilled pen.
Glimepiride
Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin throughout the day. It is approved to help adults with type 2 diabetes control blood sugar alongside diet and exercise. It comes as a tablet taken once daily, usually with the first main meal.
Trulicity vs. Glimepiride Side Effects
Trulicity
Glimepiride
Trulicity vs. Glimepiride Dosage
Trulicity
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 0.75 mg once weekly | Weeks 1-4 |
| Maximum dose | 4.5 mg once weekly | Week 13 onward |
| Dose changes | 3 increases | Every 4 weeks |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Trulicity
| STAGE | DOSE | WHEN |
| Starting dose | 0.75 mg once weekly | Weeks 1-4 |
| Maximum dose | 4.5 mg once weekly | Week 13 onward |
| Dose changes | 3 increases | Every 4 weeks |
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Trulicity vs. Glimepiride Indications
Trulicity
Trulicity is FDA-approved to improve blood sugar control in adults and children 10 and older with type 2 diabetes. It also reduces the risk of major cardiovascular events in adults with heart disease or multiple risk factors. It is sometimes used off-label for weight loss in people without diabetes.
Blood sugar control in type 2 diabetes (adults and children 10+)
Cardiovascular risk reduction in adults with heart disease or risk factors
Off-label: weight loss in people without diabetes
Not approved for type 1 diabetes or diabetic ketoacidosis
Glimepiride
Glimepiride is FDA-approved to improve blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It does not carry an approved cardiovascular, weight-loss, or pediatric indication, unlike some newer diabetes drugs. It is not approved for type 1 diabetes or diabetic ketoacidosis.
Blood sugar control in adults with type 2 diabetes
Used as an adjunct to diet and exercise
Not approved for type 1 diabetes or diabetic ketoacidosis
No pediatric or cardiovascular indication
Trulicity vs. Glimepiride Pros and Cons
Trulicity
Trulicity offers once-weekly dosing and added cardiovascular protection, but it requires an injection and carries a boxed warning for thyroid tumors seen in animal studies. There is no generic version, and it costs substantially more than older oral options like glimepiride.
Pros
Only needs to be injected once a week
Also reduces cardiovascular risk in adults with heart disease
Approved for children as young as 10
Low risk of causing hypoglycemia on its own
Cons
Requires an injection instead of a pill
Boxed warning for thyroid C-cell tumors seen in animal studies
No generic version is available
Roughly $987 to $1,065 per month without insurance
Common GI side effects like nausea and vomiting
Glimepiride
Glimepiride is a low-cost oral option with decades of real-world use, but it works differently than Trulicity and carries a higher risk of hypoglycemia. It has no cardiovascular or weight-related benefit, and some studies have linked sulfonylureas to increased cardiovascular mortality risk.
Pros
Costs roughly $10 to $20 per month without insurance
Convenient once-daily tablet
Long track record of use since 1995
Generic pricing makes it widely accessible
Cons
Higher risk of hypoglycemia than Trulicity
Can cause weight gain
Possible increased cardiovascular mortality risk (UGDP study)
No cardiovascular protection benefit
Not approved for use in children
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.